Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis fisch, modify insulin sensitizing and insulinotropic actions

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 6, 2007, Pages 1452-1461

  Ko, Byoung Seob ^a   Jang, Jin Sun ^b   Hong, Sang Mee ^b   Sung, So Ra ^b   Lee, Ji Eun ^b   Lee, Mi Young ^a   Jeon, Won Kyung ^a   Park, Sunmin ^b  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

Glucose; Insulin; Insulinotropic action; Islet; Peroxisome proliferation activated receptor (PPAR)

Indexed keywords

CELLS; CHEMICAL ACTIVATION; DISEASE CONTROL; GAMMA RAYS; GLUCOSE; INSULIN;

INSULINOTROPIC ACTION; PEROXISOME PROLIFERATION-ACTIVATED RECEPTOR (PPAR)-Γ;

PLANTS (BOTANY);

ANTIDIABETIC AGENT; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN 3T3; CELL SURVIVAL; CHEMISTRY; DIABETES MELLITUS; DRUG EFFECT; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; GLYCYRRHIZA URALENSIS; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL SURVIVAL; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; GLYCYRRHETINIC ACID; GLYCYRRHIZA URALENSIS; GLYCYRRHIZIC ACID; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MICE; PPAR GAMMA;

GLYCYRRHIZA; GLYCYRRHIZA URALENSIS; MUS;

EID: 34347329278     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60533     Document Type: Article

References (30)

1. Kahn, S. E., The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46, 3-19 (2003).
2. Chiasson, J. L., and Rabasa-Lhoret, R., Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes, 53, S34-S38 (2004).
3. Weir, G. C., and Bonner-Weir, S., Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes, 53, S16-S21 (2004).
4. Perseghin, G., Caumo, A., Arcelloni, C., Benedini, S., Lanzi, R., Pagliato, E., Sereni, L. P., Testolin, G., Battezzati, A., Comi, G., Comola, M., and Luzi, L., Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care, 26, 2112-2118 (2003).
5. Nakagawa, K., Kishida, H., Arai, N., Nishiyama, T., and Mae, T., Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-A(y) mice. Biol. Pharm. Bull., 27, 1775-1778 (2004).
6. Sung, M. W., and Li, P. C., Chemical analysis of raw, dry-roasted, and honey-roasted licorice by capillary electrophoresis. Electrophoresis, 25, 3434-3440 (2004).
7. Kuroda, M., Mimaki, Y., Sashida, Y., Mae, T., Kishida, H., Nishiyama, T., Tsukagawa, M., Konishi, E., Takahashi, K., Kawada, T., Nakagawa, K., and Kitahara, M., Phenolics with PPAR-gamma ligand-binding activity obtained from licorice (Glycyrrhiza uralensis roots) and ameliorative effects of glycyrin on genetically diabetic KK-A(y) mice. Bioorg. Med. Chem. Lett., 13, 4267-4272 (2003).
8. Mae, T., Kishida, H., Nishiyama, T., Tsukagawa, M., Konishi, E., Kuroda, M., Mimaki, Y., Sashida, Y., Takahashi, K., Kawada, T., Nakagawa, K., and Kitahara, M., A licorice ethanolic extract with peroxisome proliferator- activated receptor-gamma ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. J. Nutr., 133, 3369-3377 (2003).
9. Takii, H., Kometani, T., Nishimura, T., Nakae, T., Okada, S., and Fushiki, T., Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice. Biol. Pharm. Bull., 24, 484-487 (2001).
10. Kieffer, T. J., and Habener, J. F., The glucagon-like peptides. Endocr. Rev., 20, 876-913 (1999).
11. Drucker, D. J., Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology, 122, 531-544 (2002).
12. Buteau, J., Roduit, R., Susini, S., and Prentki, M., Glucagon-like peptide-1 promotes DNA synthesis, acti vates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia, 42, 856-864 (1999).
13. Lee, C. S., De Leon, D. D., Kaestner, K. H., and Staffers, D. A., Regeneration of pancreatic islets after partial pancreatectomy in mice does not involve the reactivation of neurogenin-3. Diabetes, 55, 269-272 (2006).
14. Sabbioni, C., Mandrioli, R., Ferranti, A., Bugamelli, F., Saracino, M. A., Forti, G. C., Fanali, S., and Raggi, M. A., Separation and analysis of glycyrrhizin, 18α-glycyrrhetinic acid and 18β-glycyrrhetinic acid in liquorice roots by means of capillary zone electrophoresis. J. Chromatogr. A, 1081, 65-71 (2005).
15. Squires, P. E., Hauge-Evans, A. C., Persaud, S. J., and Jones, P. M., Synchronization of Ca(2+)-signals within insulin-secreting pseudoislets: effects of gap-junctional uncouplers. Cell Calcium, 27, 287-296 (2000).
16. Choi, S. B., Jun, D. W., and Park, S., The insulin sensitizing effect of homoisoflavone-enriched fraction in Liriope platyphylla Wang et Tang via the PI3-kinase pathway. Life Sci., 75, 2653-2664 (2004).
17. Shimaya, A., Kovacina, K. S., and Roth, R. A., On the mechanism for neomycin reversal of wortmannin inhibition of insulin stimulation of glucose uptake. J. Biol. Chem., 279, 55277-55282 (2004).
18. Hennige, A. M., Burks, D. J., Ozcan, U., Kulkarni, R. N., Ye, J., Park, S., Schubert, M., Fisher, T. L., Dow, M. A., Leshan, R., Zakaria, M., Mossa-Basha, M., and White, M. F., Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J. Clin. Invest., 112, 1521-1532 (2003).
19. Cantelli-Forti, G., Maffei, F., Hrelia, P., Bugamelli, F., Bernardi, M., D'Intino, P., Maranesi, M., and Raggi, M. A., Interaction of licorice on glycyrrhizin pharmacokinetics. Environ. Health Perspect., 102, 65-68 (1994).
20. Ding, L., Huang, X., Yang, J., Bian, X., Zhang, Z., and Liu, G., Determination of glycyrrhetic acid in human plasma by LC-ESI-MS. J. Pharm. Biomed. Anal., 40, 758-762 (2006).
21. Hou, Y. C., Hsiu, S. L., Ching, H., Lin, Y. T., Tsai, S. Y., Wen, K. C., and Chao, P. D., Profound difference of metabolic pharmacokinetics between pure glycyrrhizin and glycyrrhizin in licorice decoction. Life Sci., 76, 1167-1176 (2005).
22. Hammarstedt, A., Andersson, C. X., Sopasakis, R. V., and Smith, U., The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot. Essent. Fatty Acids, 73, 65-75 (2005).
23. Jiang, C., Ting, A. T., and Seed, B., PPAR-r agonists inhibit production of monocyte inflammatory cytokines. Nature (Lond.), 391, 82-86 (1998).
24. Berstein, L. M., Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer. Cancer Lett., 224, 203-212 (2005).
25. 2+ oscillations in clusters of mouse pancreatic islet cells. J. Physiol., 520, 839-849 (1999).
26. Le Gurun, S., Martin, D., Formenton, A., Maechler, P., Caille, D., Waeber, G., Meda, P., and Haefliger, J. A., Connexin-36 contributes to control function of insulin-producing cells. J. Biol. Chem., 278, 37690-37697 (2003).
27. Gilon, P., Ravier, M. A., Jonas, J. C., and Henquin, J. C., Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes, 51, S144-S151 (2002).
28. Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M. F., and Montminy, M., cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev., 17, 1575-1580 (2003).
29. Park, S., Dong, X., Fisher, T. L., Dunn, S. L., Omer, A. K., Weir, G., and White, M. F., Exendin-4 promotes IRS2 signaling to mediate pancreatic beta-cell growth and function. J. Biol. Chem., 281, 1159-1168 (2006).
30. Choi, S. B., Jang, J. S., and Park, S., Estrogen and exercise may enhance beta-cell function and mass via IRS2 induction in ovariectomized diabetic rats. Endocrinology, 146, 4786-4794 (2005).